メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 19 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 28 |
|---|
| ページあたり内部リンク平均 | 44.47 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| toripalimab | 1 |
| Coherus | 0.647059 |
| treatment | 0.460945 |
| doi | 0.449759 |
| line | 0.427271 |
| NPC | 0.411765 |
| chemotherapy | 0.411765 |
| first | 0.389105 |
| metastatic | 0.382353 |
| patients | 0.37354 |
| antibody | 0.313443 |
| Junshi | 0.295005 |
| recurrent | 0.294118 |
| our | 0.289253 |
| was | 0.269856 |
| FDA | 0.264706 |
| monoclonal | 0.258129 |
| Biosciences | 0.253309 |
| clinical | 0.253309 |
| anti | 0.249027 |
| approved | 0.247368 |
| United | 0.22488 |
| States | 0.22488 |
| China | 0.217899 |
| has | 0.207252 |
| NMPA | 0.205882 |
| ability | 0.205882 |
| risks | 0.205882 |
| its | 0.202816 |
| Epub | 0.202392 |
| approval | 0.184378 |
| Toripalimab | 0.184378 |
| use | 0.184378 |
| carcinoma | 0.179904 |
| Cancer | 0.179904 |
| investigational | 0.179904 |
| combination | 0.176471 |
| survival | 0.176471 |
| granted | 0.176471 |
| forward | 0.176471 |
| looking | 0.176471 |
| statements | 0.176471 |
| any | 0.176471 |
| uncertainties | 0.176471 |
| advanced | 0.16594 |
| nasopharyngeal | 0.157416 |
| expanded | 0.157416 |
| TopAlliance | 0.149682 |
| drug | 0.149613 |
| information | 0.147503 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| antibody | monoclonal | 3.409115 | 56 |
| States | United | 3.307793 | 40 |
| Biosciences | Junshi | 3.136346 | 60 |
| com | topalliancebio | 3.08604 | 42 |
| metastatic | recurrent | 3.069243 | 40 |
| anti | monoclonal | 3.060175 | 48 |
| info | topalliancebio | 3.049304 | 43 |
| company | info | 2.960446 | 61 |
| forward | looking | 2.906252 | 24 |
| looking | statements | 2.906252 | 24 |
| risks | uncertainties | 2.886957 | 25 |
| line | treatment | 2.690299 | 57 |
| investigational | use | 2.657214 | 28 |
| anti | antibody | 2.654668 | 44 |
| efficacy | safety | 2.643929 | 20 |
| carcinoma | nasopharyngeal | 2.596749 | 24 |
| access | expanded | 2.596749 | 24 |
| environment | operate | 2.580358 | 16 |
| remaining | true | 2.580358 | 16 |
| inspirations | true | 2.580358 | 16 |
| continue | let | 2.580358 | 16 |
| let | science | 2.580358 | 16 |
| pragmatism | science | 2.580358 | 16 |
| drive | pragmatism | 2.580358 | 16 |
| finding | objectives | 2.580358 | 16 |
| cures | finding | 2.580358 | 16 |
| immuno | oncology | 2.580358 | 16 |
| communities | serve | 2.45393 | 16 |
| forth | set | 2.45393 | 16 |
| development | innovative | 2.422506 | 27 |
| overall | survival | 2.382328 | 15 |
| believe | remaining | 2.369838 | 16 |
| https | www | 2.357841 | 15 |
| free | progression | 2.348488 | 12 |
| containing | platinum | 2.348488 | 12 |
| checkpoint | inhibitor | 2.348488 | 12 |
| Commission | Exchange | 2.348488 | 12 |
| Access | Expanded | 2.348488 | 12 |
| Access | refers | 2.348488 | 12 |
| criteria | when | 2.348488 | 12 |
| You | may | 2.348488 | 12 |
| may | reference | 2.348488 | 12 |
| forward | statements | 2.32836 | 18 |
| dedicated | discovery | 2.263293 | 16 |
| Drug | Food | 2.263293 | 16 |
| Securities | filed | 2.208955 | 12 |
| Exchange | Securities | 2.208955 | 12 |
| environment | preserve | 2.208955 | 12 |
| criteria | forth | 2.208955 | 12 |
| They | include | 2.208955 | 12 |